Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Politics

Speaker Johnson ekes out healthcare bill victory after House GOP Obamacare rebellion

by admin December 18, 2025
December 18, 2025
Speaker Johnson ekes out healthcare bill victory after House GOP Obamacare rebellion

House Republicans passed a bill they say will lower healthcare costs for a broad swath of Americans by roughly 11%.

It’s a victory for Speaker Mike Johnson, R-La., who has been managing deep divisions within the House GOP on the topic of healthcare as insurance premiums are set to spike across the country in a matter of weeks.

One glaring issue that remains unresolved is Obamacare subsidies, which were enhanced during the COVID-19 pandemic but are set to expire at the end of this year.

The legislation passed 216 to 211. Just one Republican, Rep. Thomas Massie, R-Ky., voted against it along with all House Democrats.

The bill’s passage comes hours after a group of moderate Republicans joined a Democrat-led discharge petition to force a vote on extending the subsidies for another three years.

A discharge petition is a mechanism for overriding the will of House leaders to get a chamberwide vote on specific legislation, provided it has support from a majority of lawmakers. It sets up the legislation for a vote sometime in the new year.

Each of the four House Republicans made clear that backing Democrats’ bill was not their first choice, but they felt they were left with few options after Johnson made clear this week that there would not be a separate vote on extending the subsidies before the end of this year.

But the majority of House Republicans are against extending the subsidies, at least without significant reforms. Conservatives have argued the subsidies amount to throwing more money at a long-broken system that does little to tackle the actual cost of healthcare.

‘Obamacare has been an unmitigated disaster for 15 years, crushing families with high premiums and rampant fraud while enriching insurance companies. It’s time for conservatives to get serious about advancing policies that can become law and therefore actually reduce costs,’ Republican Study Committee Chairman August Pfluger, R-Texas, who called the House bill a ‘solid first step,’ told Fox News Digital.

Republicans who are for extending them have also conceded that reforms are needed, but have positioned a short-term extension as the best course of action to buy more time to work on an off-ramp.

The House GOP bill, the Lower Health Care Premiums for All Americans Act, includes provisions to codify association health plans, which allow small businesses and people who are self-employed to band together to purchase healthcare coverage plans, giving them access to greater bargaining power.

Republicans also plan to appropriate funding for cost-sharing reductions beginning in 2027, which are designed to lower out-of-pocket medical costs in the individual healthcare market. House GOP leadership aides said it would bring down the cost of premiums by 12%.

New transparency requirements for pharmacy benefit managers (PBMs) are also in the legislation, aimed at forcing PBMs to be more upfront about costs to employers.

PBMs are third parties that act as intermediaries between pharmaceutical companies and those responsible for insurance coverage, often responsible for administrative tasks and negotiating drug prices.

PBMs have also been the subject of bipartisan ire in Congress, with both Republicans and Democrats accusing them of being part of a broken system to inflate health costs.

The nonpartisan Congressional Budget Office (CBO) estimated that enacting the bill would reduce the federal deficit by $35.6 billion for a 10-year period through 2035.

If the bill became law, it would also decrease the number of people with health insurance by an average of 100,000 per year between 2027-2035 and lower gross benchmark premium costs by an average 11% through 2035, CBO said.

However, it’s not immediately clear whether it will be taken up by the Senate.

Republicans in the upper chamber failed to advance their own healthcare plan last week after also rejecting Democrats’ plan to extend the Obamacare subsidies.

This post appeared first on FOX NEWS

previous post
Dan Bongino to resign from FBI deputy director role in January
next post
Trump attends solemn dignified transfer for Iowa guardsmen, civilian killed in Syria ISIS attack

Related Posts

White House sends mixed signals in Russia ‘hoax’...

July 25, 2025

Wisconsin Supreme Court decides abortion case that prompted...

July 3, 2025

Trump’s victory could give boost to Brazil’s Bolsonaro’s...

January 10, 2025

Democratic lawmakers criticize Israel’s defensive strikes against Iran’s...

June 14, 2025

CIA director blasts Democrat’s ‘offensive line of questioning’...

March 27, 2025

Schumer-linked PAC accuses senator of stock ‘greed,’ but...

September 10, 2025

Trump says Biden admin ‘knows what is happening’...

December 17, 2024

New book sheds light on Harris decision to...

July 10, 2025

Trump administration defends US and Israeli sovereignty with...

June 6, 2025

Ted Cruz clashes with key Democrat over ‘second...

April 3, 2025

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • MN lawmaker says ‘unbelievable’ assisted-living fraud scheme includes indicted figure still getting state pay
  • Maduro erupts as Trump vows massive blockade around Venezuela — decries ‘warmongering threats’
  • Trump gets fresh digs in at Biden, Obama with new plaques added to White House Presidential Walk of Fame

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    December 18, 2025
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    December 18, 2025
  • MN lawmaker says ‘unbelievable’ assisted-living fraud scheme includes indicted figure still getting state pay

    December 18, 2025
  • Maduro erupts as Trump vows massive blockade around Venezuela — decries ‘warmongering threats’

    December 18, 2025
  • Trump gets fresh digs in at Biden, Obama with new plaques added to White House Presidential Walk of Fame

    December 18, 2025
  • Trump attends solemn dignified transfer for Iowa guardsmen, civilian killed in Syria ISIS attack

    December 18, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

    September 19, 2025
  • 3

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 4

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 7

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
Promotion Image

banner

Categories

  • Business (602)
  • Investing (2,653)
  • Politics (3,214)
  • Stocks (970)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved